VCValeria Nikolayevna Chapurina

Valeria Nikolayevna Chapurina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valeria Nikolayevna Chapurina has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antigen-presenting subsets of neutrophils: A diagnostic marker of clinical efficiency of immunomodulatory therapy with synthetic thymic hexapeptide in children with acute hematogenous osteomyelitis

    by I. V. Nesterova, G. A. Chudilova, N. K. Barova, A. D. Safontseva, E. A. Poezzhaev, S. V. Kovaleva, V. N. Chapurina, E. A. Chicherev, Yu. V. Teterin, L. V. Lomtatidze, et al.

    The multiple functions of neutrophilic granulocytes (NG) are associated with various subsets and phenotypes of these cells. Previously, in children with severe purulent inflammatory diseases, a correlation was found between the severity of disease and contents of CD66b + CD16 + CD33 + HLA-DR + NG (APC-NG) subset. Thus, the determination of the APC-NG subset may serve as a valuable diagnostic tool and an efficiency index during complex therapy in severe purulent-inflammatory diseases. Our goal was to assess the dynamic changes in APC-NG levels in children with AHO in comparison with the dynamics of indicators of clinical effectiveness during immunomodulatory therapy with a synthetic thymic hexapeptide (HP). Materials and methods. The study group (SG) included 15 children aged 10-15 years with acute hematogenic osteomyelitis (AHO), the comparison group (CG) consisted of 13 conditionally healthy children. The contents of NG expressing CD66b, CD16, CD33, HLA-DR (FC500, Beckman Coulter), and expression density of these molecules was evaluated in peripheral blood (PB) of patients and controls. The PB samples were collected before surgery, on the 10 th day of therapy, and before discharge. The immunological parameters of control samples were studied once. The amounts of APC-NG were found to be increased by 18 times in study group before treatment, being decreased by 1.9 times on the 10 th day after the beginning of treatment, and by 3.8 times at the time of discharge (20-25 th day). However, the content of APC-NG after treatment did not reach the CG levels. Moreover, a decreased number of APC-NG correlated with positive clinical dynamics: there was an earlier regression of general and local symptoms. A delay in positive changes of APC-NG was observed in the absence of clinical efficiency, thus requiring a revision of therapeutic strategy, and changes of antibacterial therapy. Conclusion: The study demonstrated high clinical efficacy of thymic HP in the complex treatment of children with AHO and a diagnostic potential of the APC-NG contents as a diagnostic marker for monitoring efficacy of postsurgical treatment of pediatric AHO patients. This marker may also serve as a tool that allows for timely correction of AHO treatment at the in- and outpatient stages.

  • Neutrophil granulocytes in the immunopathogenesis of adenovirus pneumonia of various severity in adult patients

    by G.A. Chudilova, I.V. Nesterova, V.N. Gorodin, V.A. Matushkina, V.N. Chapurina, Yu.V. Teterin

    Neutrophilic granulocytes (NG) are the first to migrate to the site of infection, providing antiviral protection through various mechanisms: phagocytosis, degranulation, production of reactive oxygen species, synthesis of cytokines, formation of NETs and ectosomes, and may play a key role in determining the course and outcome of the disease. However, the functional activity of NG in adenovirus infection is poorly understood. Objective: to clarify the features of neutrophil granulocyte functioning in adults with community-acquired adenovirus pneumonia (CAAP) of varying severity. Materials and methods. 30 male military personnel with a confirmed diagnosis of adenovirus pneumonia (J12.0) at the age of 37(31; 40) years in the acute period — 5.5(5.0; 7.5) days from the onset of the disease, hospitalized in the Krasnodar Specialized Clinical Infectious Diseases Hospital of the Ministry of Health, were studied. Study Group 1 (SG1) consisted of 22 patients with mild pneumonia, Study Group 2 (SG2) consisted of 8 patients with severe pneumonia, and the comparison group (CG) consisted of 22 healthy volunteers aged 37(31; 40). Immunophenotyping of lymphocyte subpopulations and NG — CD64-CD16+CD32+CD11b+, CD64+CD16+CD32+CD11b+ (FC500 «Beckman Coulter», USA), phagocytic and NADPH-oxidase activity of NG was performed. Results. We have established the disorders of antimicrobial defense in patients of both groups with CAP, more pronounced in SG2: a decrease in the number of lymphocytes, NK-, T cells, T helpers and cytotoxic lymphocytes; insufficient production of IgM and IgG. In addition, we revealed an increase in the number of NG, the proportion of band-nucleated forms, changes in the ratio of NG subset and their phenotype, associated with hyperactivation, a significant increase in NADPH-oxidase activity, a decrease in the phagocytic activity of NG. Conclusion. Immune system dysfunctions in adults with CAAP are multifactorial and involve both innate and adaptive components of anti-infective immunity. In CAAP, NG are a critical component of the immune response necessary for controlling infection, but when dysregulated, they become a significant factor in pathogenesis, determining the severity of the disease and the risk of complications. This necessitates the assessment of immune status, particularly NG, and the development of immunotherapy methods.

  • Thymus and thymic peptides: stages of the long road from experimental research to implementation in clinical practice (review)

    by I.V. Nesterova, L.V. Lomtatidze, G.A. Chudilova, S.V. Kovaleva, V.N. Chapurina, S.N. Pikturno

    Peptides isolated from the thymus and synthesized thymomimetics, due to their rich spectrum of multivariate effects, are unique structures that implement mutual feedback between the nervous, immune and endocrine systems through intercellular interactions and intracellular signaling pathways. This review not only focuses on the clinical effectiveness of using these substances to reconstruct the immune system, but also attempts to summarize the current knowledge about the mechanisms of thymic factors. Thus, the search for immunomodulators as an alternative therapeutic strategy for balancing the body’s response to excessive inflammation at the immune depression led to the discovery of previously unknown mechanisms of action of the thymic synthetic pentapeptide TP5. Our experience with synthetic thymomimetics in vitro experiments and clinical practice for various secondary immunodeficiency (SID) conditions is presented. We have proven the fact of restoration of the immune system in infectious and inflammatory diseases against the background of restoration of the functional capacity of neutrophilic granulocytes when using synthetic thymic hexapeptide (HP), which is an analogue of the active center of thymopoietin. A personalized approach to patient management with the identification of the pathological immunophenotype of SID justifies the use of synthetic thymomimetics and makes their use promising. There is no doubt that understanding the subtle mechanisms of the multi-vector action of thymic immunomodulators, demonstrated in the article, can become a point of support in determining the optimal treatment strategy for various pathologies, especially in immunosenescence, as well as immune-dependent diseases associated with atypical infectious and inflammatory processes.

  • Open Access

    Reconstructive immunomodulation under the influence of thymic hexapeptide of number and phenotype of subsets CD16+CD62L+CD11b+CD63- and CD16+CD62L+CD11b+CD63+ of neutrophilic granulocytes in children with acute destructive pneumonia, is associated with positive clinical efficacy

    by Irina V. Nesterova, Galina A. Chudilova, Anastasia D. Safontseva, Valeriya N. Chapurina, Darina E. Lyagusha, Natusya K. Barova

    Dysfunction of neutrophilic granulocytes (NG) is a decisive factor in the development and progression of atypical purulent-inflammatory diseases, including acute destructive pneumonia (ADP) in children. A promising approach is to include immunocorrective therapy in complex treatment, thus promoting recovery of NG functions. The objective of this study was to assess the features of defective NG functioning associated with changes in relative contents and phenotype of CD16+CD62L+CD11b+CD63- and CD16+CD62L+CD11b+CD63+ neutrophil subsets in children with ADP, to evaluate clinical and immunological effectiveness of immunomodulatory therapy in complex postoperative treatment using a pharmaceutical drug with a synthetic thymic hexapeptide (pdHP) being the active substance. The study included 21 children aged 2-4 years: with a diagnosis of ADP (study group, SG) before complex treatment, and a group after treatment with hexapeptide (SG1). The comparison group included 20 conditionally healthy children (CG), Twenty children treated for ADP comprised the archival comparison group (aCG). The functions of NG were assessed by the content of CD16+CD62L+CD11b+CD63- and CD16+CD62L+CD11b+CD63+ subsets using FC500 (Beckman Coulter) device. We also determined indices characterizing phagocytosis (%PAN, PN, PI, %D, ID), NADPH oxidase activity (%PPC, MCI) in the NBT test. We have found a phenotypic transformation of physiological subset to CD16dimCD62LdimCD11bbrightCD63- NG with defective immune properties, a 3-fold increase in the content of NG subset with hyperactivated phenotype CD16brightCD62LbrightCD11bbrightCD63bright (p 0.05), a defect in phagocytic function, but increased oxidase activity (p1, 2 0.05) in immunocompromised children with ADP. After complex treatment with the inclusion of hexapeptide, we observed normalization of NG effector functions associated with phenotype remodeling and restoration of the subpopulation ratio. Positive clinical dynamics was revealed when compared with aCG children receiving conventional therapy, i.e., a significant reduction in fever duration (|δ| = 0.98), respiratory failure (|δ| = 0.99), more rapid regression of pleural effusion (|δ| = 0.96) and early removal of drainages (|δ| = 1.00). The obtained results indicate a pronounced positive clinical and immunological efficiency of pdHP usage in complex treatment of children with ADP.

  • Open Access

    Cellular and humoral mechanisms of immune aging

    by Irina Vadimovna Nesterova, Svetlana Valentinovna Kovaleva, Galina Anatolyevna Chudilova, Elisey Andreyevich Poezzhaev, Anna Ivanovna Pirogova, Valeria Nikolayevna Chapurina, Lyudmila Viktorovna Lomtatidze, Yuriy Valerievich Teterin, Svetlana Nikolaevna Pikturno, Anastasia Dmitriyevna Safontseva

    Despite significant advancements in extending average life expectancy, challenges persist in enhancing the quality of life for elderly and senile individuals, preventing and treating age-associated diseases and managing geriatric syndromes. The immune system plays a crucial role in aging, undergoing extensive functional changes collectively referred to as immunosenescence. Cellular aging within the immune system is associated with telomere shortening, proteostasis loss, mitochondrial dysfunction, DNA damage, and oxidative stress. Senescent cells are characterized by resistance to apoptosis, cell cycle arrest, and abnormal production of pro-inflammatory cytokines, leading to chronic low-grade inflammation. Concurrently, the effector mechanisms of the immune response become depleted, resulting in a reduced ability of the immune system to adequately respond to antigenic stimuli. Thymic atrophy, depletion of bone marrow niches, a shift in hematopoiesis toward the myeloid lineage, and alterations in lymphocyte subpopulation ratios occur. Additionally, the effector functions of neutrophil granulocytes are impaired. However, the nature of these functional changes in immunosenescence remains insufficiently studied, requiring further research to determine the specific dysfunctions of neutrophil granulocytes in aging.


  • Open Access

    In vitro effects of recombinant IFNα2B on the content of antigen-presenting CD66b+CD16+CD33+HLA-DR+ subset of neutrophils in children with acute osteomyelitis

    by I. V. Nesterova, Galina A. Chudilova, Yu. V. Teterin, E. A. Chicherev, V. N. Chapurina, V. A. Tarakanov, N. K. Barova

    Negative impact of S. aureus, seems to be a sufficient condition for the spread of the infectious process in the bone in acute osteomyelitis (AOM) due to its altered elimination caused by dysfunction of the immune system (IS), in particular, of neutrophilic granulocytes (NG). Correction of NG dysfunction in AOM under the influence of immunotropic substances and cytokines via modulation of the NG phenotypic subsets is of sufficient interest. Our aim was to evaluate the in vitro effects of recombinant IFNá2b on the number and phenotype of CD66b+CD16+CD33+HLA-DR-, CD66b+CD16+CD33+HLA-DR+ subsets and on phagocytic function of neutrophilic granulocytes in acute osteomyelitis in children. The study of peripheral blood (PB) samples from children aged 8-15 years was carried out as follows: patients with АOM (n = 24) comprised study group 1 (SG1), healthy children (n = 13) were included into comparison group (CG). PB samples of children with AOM were incubated with recIFNá2b (50 IU/µL, 60 min, 37 °C.) in the study group 1a (SG1a). Before and after incubation with recIFNá2b, the number of NG subsets CD66b+CD16+CD33+HLA-DR-, CD66b+CD16+CD33+HLA-DR+ and the density values of receptor expression by fluorescence intensity (MFI) were also determined (FC 500, Beckman Coulter, США). Phagocytic activity of NCs was evaluated as the contents of actively phagocytic NCs (%PhAN), volume of the engulfed S. aureus (strain 209) by assessing their phagocytic number (PhN), phagocytic index (PhI). Bacterial killing was determined as the percentages of microbe digestion (%D), digestion index (DI). The cells from AOM patients revealed a subset expressing the HLA-DR receptor – СD66b+CD16+CD33+HLA-DR+NG, which is absent in the PB of CG children. The cells with primed phenotype exhibited an increased expression density of activation receptors CD16 and CD66b. Incubation of PB in AOM with recIFNá2b led to an increased proportion of CD66b+CD16+CD33+HLA-DR+ NG subset which showed active phagocytosis and improved digestion processes. The present study shows the emergence of activated subset of “long-lived” CD66b+CD16+CD33+HLA-DR+ NCs in children with AOM. This subpopulation has APC features, by presenting AG to T lymphocytes, with preserved effector properties. In an in vitro experimental system, a positive effect of recIFNá2b was demonstrated, leading to an increased number of NGs of the CD66b+CD16+CD33+HLA-DR+ subset and recovery of S. aureus phagocytosis by NGs, thus being promising in the future for development of new approaches to optimization of complex therapy in the postoperative period of AOM treatment, prevention of complications and the opportunity to alleviate the disorders in the immune system.

  • Open Access

    Positive effects of recombinant interferon α2b on the phenotype of CD16+INFα/βR1-CD119+, CD16+INFα/βR1+CD119- neutrophil granulocyte subset in patients with post-COVID syndrome and herpesvirus infections

    by M. G. Atazhakhova, Irina V. Nesterova, G. A. Chudilova, V. A. Matushkina, S. V. Kovaleva, V. N. Chapurina

    Post-COVID syndrome (PCS) is a multisystem inflammatory condition with manifestations of chronic fatigue syndrome (CFS) and cognitive disorders (CD), along with reactivation of chronic herpesvirus infections (HVI). The PCS manifestations require studying the molecular mechanisms associated with the production of IFN and receptor functions of neutrophil granulocytes (NG), which is relevant and promotes the search for immunotherapeutic strategies in patients with PCS. Our objective was to study the in vitro effects of recombinant interferon α2b (recIFNα2b) on the phenotype of CD16+IFNα/βR1-CD119+, CD16+IFNα/ βR1+CD119+ subsets and functional activity of NG in patients with post-COVID syndrome and herpesvirus infections. Materials and methods: 45 patients (24-60 years old) with PCS and HVI (HSV 1, EBV, HHV6, CMV) comprised the study group 1 (SG1). A questionnaire was conducted to assess the severity of PCS symptoms using a point scale. We performed a study of the content and phenotype of NG subsets, i.e., the CD16+IFNα/βR1-CD119+, CD16+IFNα/βR1+CD119-, CD16+IFNα/βR1+CD119+ subpopulation, phagocytic and NADPH oxidase function of NG before and after in vitro incubation with recIFNα2b (50 IU/ µL, for 60 min, at 37 °C) in the study group 1a (SG1a). The comparison group (CG) of 30 volunteers examined during the pre-COVID period. Results: We revealed more pronounced clinical manifestations of CFS and CD in SG1 patients with mixed HVI, than in mono-HVI cases. Increased expression density of all receptors was registered on CD16+IFNα/βR1+CD119-NG and CD16+IFNα/βR1-CD119+ NG, thus suggesting the NG activation with initiation of cytotoxicity or NETosis, a decrease in phagocytic function and intensity of NADPH oxidase activity with depletion of NG reserve capacity in SG1. We have obtained some data on the positive effect of recIFNα2b in vitro (SG1a), e.g., decreased CD16 expression density and enhancement of IFNα/βR1 receptor expression in the CD16+IFNα/βR1+CD119- subset. In the CD16+IFNα/βR1-CD119+ subset, we have found persistence of increased MFI CD16 and MFI CD119 receptors, restoration of defective NG phagocytic function and reduced excessive activity of NADPH oxidases. Conclusion: The positive effects of the recIFNα2b influence on deficient function of NG in PCS patients suggest an oppoptunity of using immunotherapy with a recIFNα2b-based drug, combined with highly active antioxidants for treatment of various PCS manifestations including CFS, CD, HVI, thus, probably, ensuring adequate functioning of antiviral and regulatory mechanisms of the immune system.

  • Open Access

    Immune system dysfunction in purulent inflammatory diseases of the maxillofacial area in pediatric patients

    by Marina N. Mitropanova, T. A. Ponomarenko, G. A. Chudilova, Yu. V. Teterin, V. N. Chapurina

    The issues of treatment of purulent inflammatory diseases of the maxillofacial region (PMMA) are quite urgent, due to increasing number of such patients. Their clinical course is getting worse, and the efficiency of antibiotic therapy is decreasing. Clinical outcomes of purulent maxillofacial pathology in children are complicated by potential severe local deformities at the growth areas of the jaw bones which are difficult to eliminate. The number of cases of prolonged and chronic inflammatory processes, development of local and general complications is increased. The reason for these complications may be an impaired susceptibility to infectious agents, which is determined by the state of the immune system. Therefore, our aim was to reveal some features of immune functions in children with purulent-inflammatory diseases of maxillofacial area. The study included a group of pediatric patients 8-17 years old with maxillofacial inflammatory diseases of the maxilla (the study group), and 13 conditionally healthy children (the comparison group). The contents of T cells (CD3+CD19-, CD3+CD4+, CD3+CD8+, CD3+CD4+/CD3+CD8+), and В cells (CD3-CD19+), NK (CD3-CD16+CD56+) was determined using Cytomics FC-500 (Beckman Coulter, USA);concentrations of serum IgA, IgM, IgG were determined by ELISA technique (Vector-Best, Russia). Phagocytic activity of neutrophilic granulocytes (NG) was evaluated as percentage of actively phagocytic NGs, capturing processes were assessed by appropriate phagocytic indices, and the digestive activity was evaluated against S. aureus (strain 209). Combined defects of immune response in children with maxillofacial hypertension were established: decrease of T lymphocytes contents along with decrease of T helpers and CTL ratio along with unchanged content of NK cells and B lymphocytes. Increase of IgA and IgG levels was also found. Defects of phagocytosis were revealed, primarily connected with the processes of completed phagocytosis and increased content of actively phagocytizing NG. Treatment of children suffering with purulent inflammatory diseases of maxillofacial region is still an urgent problem in dentistry. The revealed dysfunction of immune response to pathogens in the purulent maxillofacial disorders may explain a prolonged clinical course of inflammatory processes, thus determining a need for usage of immunotropic therapy in complex treatment schedules including operative aid as well as conventional drug and physiotherapeutic treatment aiming for increase of rehabilitation efficiency and prevention of postoperative complications in these patients.


  • Open Access

    Clinical and immunological efficacy of the immunomodulating hexapeptide arginyl-alpha-aspartyl-lysyl-valyl-tyrosyl-arginine in the complex postoperative treatment of children with acute osteomyelitis

    by Galina A. Chudilova, E. A. Chicherev, Yu. V. Teterin, V. N. Chapurina, V. A. Tarakanov, N. K. Barova, I. V. Nesterova

    The recurrent and persistent nature of osteomyelitis, like as associated high morbidity of patients, prolonged hospitalization and expensive treatment require development of new approaches in therapy and pathogenetic justification of the immunotropic drugs usage in complex etiopathogenetic treatment of this disorder. Our objective was to evaluate the clinical and immunological efficacy of hexapeptide (HP), arginyl-alpha-aspartyl-lysyl-valyl-tyrosyl-arginine implemented in the complex treatment of acute osteomyelitis in children during the postoperative period. 19 children aged 8-15 years with acute osteomyelitis (AOM) were studied: the study group 1 (SG1, n = 11) received a standard treatment at all the disease stages; in study group 2 (SG2, n = 8), the standard therapy was supplemented with a medical drug Imunofan, containing hexapeptide (НP) as the active substance. Prior and after the course of drug treatment, we determined the following parameters: the contents of T cells (CD3+CD19-, CD3+CD4+, CD3+CD8+, CD3+CD4+/CD3+CD8+) and B cells (CD3-CD19+), NK (CD3-CD16+CD56+) by means of Cytomics FC-500 (“Веckman Coulter”, USA), the levels of serum IgA, IgM, IgG (ELISA tests), assessment of phagocytic activity of neutrophil granulocytes (NG) with determining the ratio of actively phagocytic NG (%PhAN), capture processes (PhN, PhI) and the completeness of phagocytosis (%D, DI) tested with S. aureus (strain No. 209). In the studied groups with AOM, a decreased content of T lymphocytes, T helper cells, T lymphocytes, NK cells was revealed, along with unchanged content of B lymphocytes. In SG2, the increased IgA and IgG levesl have been shown. We have also revealed a deficiency of phagocytic function associated with the processes of phagocytosis completion. The use of immunomodulatory therapy with an HP-containing pharmaceutical drug in combination with standard treatment was associated with restoration of immunological parameters to the reference values of healthy children, thus leading to shorter febrile period, milder manifestations of intoxication, earlier periods of reconvalescence from purulent-inflammatory process, and reduced hospital stay. The obtained positive clinical and immunological effects demonstrate the expediency of targeted immunomodulatory therapy including a pharmaceutical HP-containing drug as the active substance in the complex postoperative treatment of children with AOM. Restoration of the disturbed mechanisms of anti-infectious immunity in AOM under usage of immunomodulating HP contributes to more effective elimination of pathogens and, as a result, improvement of the clinical course of the disease, as well as prevention of chronic inflammatory processes and aggravation of immune system dysfunction.


  • Open Access

    Efficiency of combined postoperative treatment including an immunomodulatory Hexapeptide in children with acute destructive pneumonia

    by V. N. Chapurina, Irina V. Nesterova, G. A. Chudilova, S. V. Kovaleva, D. E. Lyagusha, Yu. V. Teterin, N. K. Barova, V. A. Tarakanov

    Acute destructive pneumonia (ADP) is a severe purulent and septic infectious disorder of childhood, characterized by a high level of morbidity and associated with imbalance of the immune system (IS). Hence, there is an obvious need to study the immunopathogenesis of this disease in order to develop new therapeutic strategy aimed at eliminating the pathogen, detoxifying the body, relieving respiratory failure and correcting functional immune deficiency. Our aim was to perform a clinical and immunological study in order to evaluate efficiency of immunomodulatory therapy using a medical drug with hexapeptide as an active substance. This drug was included into the complex postoperative treatment of children with acute destructive pneumonia. Clinical and immunological examination of 15 children 2-5 years old with ADP was performed before (study group 1 – SG1) and after (study group 1a – SG1a) combined postsurgical treatment including immunomodulatory therapy with a Hexapeptide-based pharmaceutical (HP, Arginyl-alpha-Aspartyl-Lysyl-Valyl-Tyrosyl-Arginine). Comparison group (CG) included twenty healthy children. The contents of T and B lymphocytes, natural killer cells (NK) were measured by means of flow cytometry (CYTOMICS FC 500, USA). Serum levels of IgA, IgM, IgG (ELISA), phagocytic and microbicidal activity of neutrophil granulocytes (NG) were also evaluated. Prior to the treatment in SG1 patients, a decreased number of CD3+CD19-T lymphocytes, CD3+CD8+ TCTL lymphocytes was revealed along with significant decrease in the contents of CD3-CD16+CD56+ NK (p1-3 0.05). It was found that in children with ADP, the IgG level did not differ from indices of control group, with a decrease of IgM (p1, 2 0.05), and increased level of IgA (p 0.05). We have also found a deficiency of NG effector functions, i.e., insufficiency of active phagocytic NG with impaired capture and killing of bacterial antigen. Assays of NADPH-oxidase activity showed lacking response to both inflammation and additional induction by S. aureus. After complex treatment including immunomodulatory therapy in the SG1a group, we revealed a recovery in CD3+CD19-T lymphocyte contents, CD3+CD8+TCTL lymphocytes, CD3-CD16+CD56+ NK (p1-3 0.05). The trends towards normalization of IgA, IgM, improved NG effector functions (killing ability) were revealed due to activation of NADPH-oxidases. The restoration of immunological parameters in ADP was associated with earlier recovery from the purulent-destructive process in lungs, absence of postoperative complications including the prevention of septic process. The clinical and immunological effects of the immunomodulatory therapy program with HP-based pharmaceutical preparations suggest its potential usage during postoperative period in immunocompromised children with ADP.